Work

A Closer Look at Changes in Hemoglobin Levels in Patients with Non-Transfusion Dependent β-Thalassemia Treated with Luspatercept: Post Hoc Analysis of the Phase 2 BEYOND Trial

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-157113

Authors: Khaled M. Musallam, Ali T. Taher, John B. Porter, Antonis Kattamis, Mrudula B. Glassberg, Luciana Bueno, Jeevan K. Shetty, Frederik Lersch, Barbara Rosettani, Maria Domenica Domenica Cappellini

Institutions: American University of Beirut Medical Center, University College London, National and Kapodistrian University of Athens, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Switzerland), University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310118225

FWCI: 0.621

Cites:

Cited by: 4

Related to: 10